Press Releases
Voglibose Inhibits Postprandial Hypotension
by David Douglas
NEW YORK (Reuters Health) May 24 - The alpha-glucosidase inhibitor
voglibose can help reduce postprandial hypotension, Japanese researchers
report in the May 9th issue of Neurology.
Lead investigator Dr. Takahiro Maruta of Kanazawa University and colleagues
note that reduced blood pressure after a meal is common in the elderly
and in those with conditions such as Parkinson's disease and diabetes
mellitus. It can increase the risk of falls and coronary events.
To examine the effect of voglibose on postprandial hypotension, the
researchers studied 48 elderly subjects including those with Parkinson's
disease, multiple system atrophy and diabetes as well as elderly and
younger controls with no autonomic disorder.
Within 2 hours of 75-g glucose loading, blood pressure fell by more
than 20 mm Hg in 72.7% of the Parkinson's patients, all of those with
multiple system atrophy, 27.3% of the patients with diabetes, 23% of
the elderly controls and none of the younger controls.
Following voglibose administration, there was a significant reduction
in this drop in blood pressure. Without voglibose the mean drop was
41.5 mm Hg; with voglibose, it was 21.0 mm Hg. There was also a reduction
in the duration of postprandial hypotension under the two conditions
(52.3 minutes versus 17.3 minutes).
Summing up Dr. Maruta told Reuters Health, "Many people suffer
from symptoms due to hypotension. Our research should cast some light
on ways to help them."
Neurology 2006;66:1432-1434.
|